Adenoviruses, Human
-
Subject Areas on Research
- A compensatory base change in U1 snRNA suppresses a 5' splice site mutation.
- A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy.
- Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein.
- Direct RNA sequencing reveals m6A modifications on adenovirus RNA are necessary for efficient splicing.
- Disseminated Adenovirus Infection After Combined Liver-Kidney Transplantation.
- Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
- Effect of ionizing radiation on thymidine uptake, differentiation, and VEGFR2 receptor expression in endothelial cells: the role of VEGF(165).
- Effect of mutant IkappaB on cytokine-induced activation of NF-kappaB in cultured human RPE cells.
- Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies.
- Experimental and numerical studies of adenovirus delivery to outflow tissues of perfused human anterior segments.
- Expression analysis of the matrix GLA protein and VE-cadherin gene promoters in the outflow pathway.
- Expression of aquaporin-1 in human trabecular meshwork cells: role in resting cell volume.
- Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.
- Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors.
- Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a.
- Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin.
- Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor.
- Persistently adenovirus-infected lymphoid cells express microRNAs derived from the viral VAI and especially VAII RNA.
- Receptor class desensitization of leukocyte chemoattractant receptors.
- Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation.
- Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.
- Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system.
- Six-year retrospective surveillance of gastroenteritis viruses identified at ten electron microscopy centers in the United States and Canada.
- Structure-based high-throughput epitope analysis of hexon proteins in B and C species human adenoviruses (HAdVs).
- Studies of viral antibody responses among Amish families.
- Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex.
- VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases.
- [Apoptosis induced by adenovirus-mediated wild-type p53 expression in human pancreatic cancer cells].
- [The effect of adenovirus-mediated wild-type p53 expression on the growth of human pancreatic carcinoma cell line cells].